The First and Only FDA-Approved, Ready-to-Use Oral Solution for the Acute Treatment of Migraine with or without Aura in Adults
Expands BDSI Portfolio and Establishes Growth Platform in Neurology
Read more at globenewswire.comAll information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
The First and Only FDA-Approved, Ready-to-Use Oral Solution for the Acute Treatment of Migraine with or without Aura in Adults
Expands BDSI Portfolio and Establishes Growth Platform in Neurology
Read more at globenewswire.com